Edition:
United States

Keryx Biopharmaceuticals Inc (KERX.OQ)

KERX.OQ on NASDAQ Stock Exchange Capital Market

5.08USD
3:59pm EST
Change (% chg)

$0.15 (+3.04%)
Prev Close
$4.93
Open
$4.94
Day's High
$5.09
Day's Low
$4.86
Volume
197,662
Avg. Vol
432,350
52-wk High
$8.37
52-wk Low
$4.02

Select another date:

Wed, Feb 7 2018

BRIEF-Keryx Biopharmaceuticals Q4 Loss Per Share $0.26

* KERYX BIOPHARMACEUTICALS ANNOUNCES FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS

BRIEF-Keryx Biopharma Says Norwich Pharmaceuticals Agreed To Terminate Manufacturing Services Agreement

* KERYX BIOPHARMACEUTICALS- ON DEC 20,CO,NORWICH PHARMACEUTICALS AGREED TO TERMINATE MANUFACTURING SERVICES AGREEMENT BETWEEN CO,NPI,DATED JAN 17, 2014‍​

BRIEF-Biovectra And Keryx Biopharmaceuticals Enter Agreement For Ferric Citrate Production Expansion

* BIOVECTRA AND KERYX BIOPHARMACEUTICALS ENTER AGREEMENT FOR FERRIC CITRATE PRODUCTION EXPANSION

BRIEF-Keryx Biopharmaceuticals Q3 loss per share $0.20

* Keryx Biopharmaceuticals announces third quarter 2017 financial results

BRIEF-KERYX BIOPHARMACEUTICALS SAYS MICHAEL ROGERS APPOINTED CHAIRMAN OF BOARD

* KERYX BIOPHARMACEUTICALS ANNOUNCES CHANGES TO ITS BOARD OF DIRECTORS

BRIEF-Keryx Biopharmaceuticals Inc - co and Patheon Inc entered into a product agreement - SEC filing​

* Keryx Biopharmaceuticals Inc - co and Patheon Inc entered into a product agreement - SEC filing​

Select another date: